Comment by liamconnell

Not mentioned in the article, but one interesting area where OpenAI could play is in participant identification and recruitment for clinical trials. In fact, ChatGPT could also help operate the clinical trials which is a highly paperwork intensive business, and therefore something that AI could add value to.

Ultimately pharmaceutical companies pay up to $100,000 per participant to hospital networks these charges must be itemized as expenses from the hospital on the most part (bounties are illegal usually.) open AI would provide a cheap way in for pharmaceutical companies to identify participants given that OpenAI has an incredible perspective into the physical and psychological state of their users. Imagine how much more is shared with OpenAI compared to a clinical trial coordinator at a hospital when a psychiatric drug is being tested.

This would also give OpenAI leverage in partnering with pharmaceutical companies. OpenAI executives have stated this is a goal, but otherwise they’ve made little progress on it.

It’s wild to imagine - someone with borderline personality disorder having delusional conversations with an AI chat Bot for six months, receiving an offer to participate in a clinical trial, and then having their subsequent AI conversations used as evidence to analyze the efficacy of the drug. The ironic thing is if that person had delusions about hidden forces listening to them…they’d be RIGHT!